JPS517113A - - Google Patents

Info

Publication number
JPS517113A
JPS517113A JP50067731A JP6773175A JPS517113A JP S517113 A JPS517113 A JP S517113A JP 50067731 A JP50067731 A JP 50067731A JP 6773175 A JP6773175 A JP 6773175A JP S517113 A JPS517113 A JP S517113A
Authority
JP
Japan
Prior art keywords
june
blood plasma
water
intravascularly
subsequent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP50067731A
Other languages
English (en)
Japanese (ja)
Inventor
Suben Eriku Rosuman Urufu
Yaabesu Rindoberui Berunto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia AB filed Critical Pharmacia AB
Publication of JPS517113A publication Critical patent/JPS517113A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1244—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • C08B31/003—Crosslinking of starch
    • C08B31/006—Crosslinking of derivatives of starch
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Dispersion Chemistry (AREA)
  • Endocrinology (AREA)
  • Materials Engineering (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Nanotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
JP50067731A 1974-06-06 1975-06-06 Pending JPS517113A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7407461A SE420566B (sv) 1974-06-06 1974-06-06 Diagnostiseringsmedel for intravaskuler administrering

Publications (1)

Publication Number Publication Date
JPS517113A true JPS517113A (fr) 1976-01-21

Family

ID=20321348

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50067731A Pending JPS517113A (fr) 1974-06-06 1975-06-06

Country Status (8)

Country Link
JP (1) JPS517113A (fr)
AU (1) AU8164675A (fr)
CA (1) CA1039274A (fr)
DE (1) DE2524278A1 (fr)
FR (1) FR2273516A1 (fr)
GB (1) GB1518813A (fr)
NL (1) NL7506743A (fr)
SE (1) SE420566B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6075436A (ja) * 1983-07-13 1985-04-27 グルベ　ソシエテ　アノニム 治療用塞栓化組成物

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0093757A1 (fr) * 1981-11-12 1983-11-16 Ulf SCHRÖDER Nanosphere ou nanoparticule a sensibilite magnetique, pouvant etre administree de maniere intravasculaire, son procede de production et son utilisation
SE463651B (sv) * 1983-12-21 1991-01-07 Nycomed As Diagnostikum och kontrastmedel

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6075436A (ja) * 1983-07-13 1985-04-27 グルベ　ソシエテ　アノニム 治療用塞栓化組成物

Also Published As

Publication number Publication date
FR2273516A1 (fr) 1976-01-02
FR2273516B1 (fr) 1979-01-05
GB1518813A (en) 1978-07-26
DE2524278A1 (de) 1975-12-18
NL7506743A (nl) 1975-12-09
CA1039274A (fr) 1978-09-26
AU8164675A (en) 1976-12-02
SE7407461L (sv) 1975-12-08
SE420566B (sv) 1981-10-19

Similar Documents

Publication Publication Date Title
US5811388A (en) Delivery of drugs to the lower GI tract
EP0787017B2 (fr) Preparation diagnostique permettant la detection de helicobacter pylori
CA1165686A (fr) Agent diagnostique radioactif, et support non radioactif connexe
DE3578647D1 (de) Paramagnetische kontrastmittel fuer die anwendung in "in vivo" nmr-diagnostischen methoden und die herstellung davon.
JPS60155138A (ja) 高められた腸内吸収性を有するヘパリン製剤の製造方法及び該ヘパリン製剤
US3466361A (en) Technetium-99m labeled chelates
US4071613A (en) Stabilized alcohol solution of reducing salt formulations for use in preparing radioisotope labeled scanning agents: liver scanning technetium-99m colloid and method of preparation
GB1518813A (en) Diagnostic agent
Schilsky et al. Biliary copper excretion capacity in intact animals: correlation between ATP7B function, hepatic mass, and biliary copper excretion
Ekenved ABSORPTION FROM DIFFERENT TYPES OF IRON TABLETS‐CORRELATION BETWEEN SERUM IRON INCREASE AND TOTAL ABSORPTION OF IRON
EP0063946A1 (fr) Diagnose de la fonction rénale
Wingårdh et al. Evaluation in vitro and in vivo of two labelling techniques of different 99m Tc-dextrans for lymphoscintigraphy
EP0413145A1 (fr) Agent diagnostique radioactif
US4057618A (en) Radioiodinated bleomycin
EP0280135A2 (fr) Protéine C-inhibiteur (PCI) comme agent pharmaceutique et diagnostic, procédé de préparation d'un tel agent pharmaceutique ou diagnostic ainsi qu'un milieu contenant le PCI
Caputo et al. Letterer-Siwe disease in an octogenarian
JPS5842846B2 (ja) 肝臓および骨髄走査用テクネチウム−９９ｍ標識放射線診断剤とその製造法
Hudson et al. Tumour uptake of thallium-201 chloride
GB2055044A (en) Glucuronidase activity and/or phdependent pharmaceuticals and their methods of production and use for selective treatment of diseases
WO2023201377A3 (fr) Imagerie et traitement nucléaires améliorés par scission
Turan et al. Evaluation of 99m Tc-citrate, 67 Gacitrate and 99m Tc (V) dimercaptosuccinic acid for the scintigraphic visualization of acute appendicitis
Rosenau Dangers in the use of certain halogenated phthaleins as functional tests
JPS63170400A (ja) 放射性医薬品とその調製用高分子化合物
Perin et al. Evaluation of possible interference of anti-inflammatory drugs upon scintigraphic imaging with macrophage targeting 99mTc-J001X: Effects of methylprednisolone, dexamethasone, indomethacin and methotrexate
Järnerot et al. Olsalazine does not increase the bile acid losses in subjects with a permanent ileostomy